Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000689
Status:
COMPLETED
Last Update Posted:
2021-11-02
First Post:
1999-11-02
Brief Title:
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor GM-CSF in AIDS-Associated Large Cell Immunoblastic and Small Non-cleaved Lymphoma
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
| Lymphoma Non-Hodgkin |
Keywords:
| Name | View |
|---|---|
| Antineoplastic Agents Combined | View |
| M-BACOD protocol | View |
| Nervous System Neoplasms | View |
| Infusions Intravenous | View |
| Injections Intravenous | View |
| Leucovorin | View |
| Cytarabine | View |
| Drug Evaluation | View |
| Drug Therapy Combination | View |
| Granulocyte-Macrophage Colony-Stimulating Factor | View |
| Administration Oral | View |
| Acquired Immunodeficiency Syndrome | View |